If you spend any amount of time looking at peptide research products, you’re going to see the same thing over and over:
99% purity.
It sounds reassuring. It also sounds a lot more straightforward than it actually is.
Because when a COA says a peptide is 99% pure, that does not automatically mean that 99% of everything in the vial is the peptide you think it is.
That number usually comes from one specific type of testing, and it only tells you part of the story.
So where does the 99% number come from?
Most peptide purity results are based on HPLC, or high-performance liquid chromatography.
In very simple terms, HPLC separates the different components in a sample and shows them as peaks on a chromatogram.
The main peptide should create the largest peak. Smaller peaks can represent impurities, degradation products, or other peptide-related material.
So if a COA says:
Purity by HPLC: 99.2%
that generally means the main detected peak represented about 99.2% of the relevant peak area during that test.
That’s useful information.
But it does not mean:
99.2% of everything physically inside the vial is confirmed to be the intended peptide.
That distinction matters.
The United States Pharmacopeia takes this same broader approach when characterizing peptide reference standards. It looks at things like chromatographic impurities, water, residual solvents, counterions, and other components rather than pretending one HPLC percentage tells the whole story.
https://www.usp.org/sites/default/files/usp/document/our-work/biologics/reference_standards_to_support_quality_of_synthetic_peptide_therapeutics.pdf
HPLC is important. It just isn’t magic.
I’m not saying HPLC testing is useless. It absolutely isn’t.
HPLC is one of the main tools used to evaluate peptide purity.
But every test has a job.
HPLC is designed to help show how clean the chromatographic profile is and whether other detectable components are present.
It does not answer every possible question about identity, quantity, or total composition.
The International Council for Harmonisation specifically emphasizes that analytical methods used for purity and impurity testing need to be selective enough to separate the compound being tested from impurities and other interfering substances. It also recognizes that more than one analytical method may be needed when a single method doesn’t tell you enough.
https://database.ich.org/sites/default/files/ICH_Q2%28R2%29_Guideline_2023_1130.pdf
Basically:
A big main peak is good.
A big main peak is not the same thing as “case closed.”
What else can be in a peptide sample?
Peptide synthesis is not a perfectly clean process.
There can be a number of peptide-related or manufacturing-related impurities, including:
- truncated peptide sequences
- missing amino acids
- incomplete deprotection
- modified peptide sequences
- degradation products
- residual solvents
- water
- counterions
- residual acids such as TFA or acetate
MilliporeSigma discusses several of these common peptide synthesis impurities, including deletion sequences, truncations, incompletely deprotected peptides, and residual TFA.
https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/protein-biology/protein-purification/peptide-impurities
USP also has separate analytical procedures for substances like acetate and trifluoroacetate in peptide materials.
Why does that matter?
Because those things are not necessarily captured by simply looking at one headline purity percentage.
Purity, identity, and quantity are not the same thing
This is probably the easiest way to think about peptide testing.
There are really three separate questions.
1. Is this actually the peptide it claims to be?
That’s an identity question.
Mass spectrometry can help with this because it provides information about molecular mass.
2. How clean is the peptide sample?
That’s a purity question.
HPLC is commonly used here.
3. How much actual peptide is present?
That’s a content or assay question.
And this is where people sometimes make the mistake of treating all three questions like they are interchangeable.
They aren’t.
Identity ≠ purity ≠ peptide content.
You can have a very clean-looking chromatogram and still need additional testing to understand exactly what is present and how much.
This is why mass spectrometry matters
Let’s say a COA shows one massive HPLC peak and reports 99% purity.
Great.
But there’s still another pretty obvious question:
Is that giant peak actually the peptide it is supposed to be?
That’s where complementary testing matters.
Mass spectrometry can provide evidence that the molecular mass matches what would be expected for the peptide being tested.
So, very broadly:
HPLC helps answer:
How clean does this sample look?
Mass spectrometry helps answer:
Does the detected material match the expected molecular mass?
Different tests. Different questions.
Using both gives you a much better picture than relying on one number alone.
Why peptide impurities matter
This isn’t just researchers being overly picky about lab reports.
The FDA specifically discusses peptide-related impurities in its guidance for synthetic peptide drug products and notes that manufacturing-related impurities can potentially affect biological properties.
Now, regulated pharmaceutical manufacturing is obviously a very different world from general research material.
But the analytical principle still applies:
What the impurities are matters. How much is present matters. And a purity percentage by itself doesn’t tell you everything.
FDA guidance:
https://www.fda.gov/media/107622/download
So is 99% purity good?
Yes.
A legitimate 99% HPLC purity result is generally a positive piece of information.
It just shouldn’t be the only piece of information you look at.
Instead of seeing “99.5% purity” and stopping there, I’d ask:
- What type of testing produced that result?
- Is the COA tied to the actual batch?
- Is the full chromatogram available?
- Was identity tested separately?
- Is mass spectrometry included?
- Is the testing laboratory identified?
- Can the report actually be traced back to the product or lot being evaluated?
Those questions tell you a lot more than a giant:
99.7% PURE
banner on a product page.
The bottom line
A high HPLC purity number is useful.
It is not meaningless.
It is also not a magic stamp proving everything about a peptide sample.
The better way to evaluate peptide testing is to look at the whole picture.
HPLC tells you something.
Mass spectrometry tells you something else.
Lot-specific testing matters.
The actual report matters.
And understanding what a test does — and what it does not do — is a lot more useful than blindly trusting a percentage.
That’s really the whole point of Pep Compass.
Not telling you what to buy.
Not pretending every COA means the same thing.
Just helping you understand what you’re actually looking at.
Research Use Only
Pep Compass provides educational information related to peptide research and analytical testing. Nothing on this site is intended as medical advice, treatment guidance, dosing guidance, or a recommendation for human use or consumption.
Leave a comment